Chinese automakers overtake U.S. rivals in sales for the first time

New energy vehicles for export at Lianyungang Port, Jiangsu Province, China, on April 25, 2024.  Nurphoto…

Westlate Chemical shares ‘current valuation fair’ says RBC Capital By Investing.com

On Friday, RBC Capital maintained a Sector Perform rating on Westlake Chemical Corporation (NYSE:) with a…

A2IM CEO Dr. Richard James Burgess to step down after 10 years

Dr. Richard James Burgess is stepping down as President and CEO of The American Association of…

All the market-moving Wall Street chatter from Friday

(This is CNBC Pro’s live coverage of Friday’s analyst calls and Wall Street chatter. Please refresh…

Evercore ISI sets fresh target on AZZ Inc shares, cites transformation By Investing.com

On Friday, Evercore ISI initiated coverage on AZZ Inc . (NYSE:) shares, a galvanized steel and…

G7 taps Moscow’s frozen assets in support of Ukraine

A simple principle underpins a contentious Thursday decision by the U.S. and key allies to tap…

ASX shares target reduced by UBS, highlights competitive threats By Investing.com

On Friday, UBS adjusted its outlook on ASX Limited (ASX:AU) (OTC: ASXFY) shares, reducing the price…

India records ‘longest’ heatwave, Delhi faces water crisis

People filling water in plastic cans from a water supply tanker at Chanakyapuri, Delhi on June…

Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease

MADRID, June 14, 2024 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing…

Bank of Japan set to reduce JGB purchases, stands pat on interest rate

The Bank of Japan is largely expected to hold interest rates steady at the end of…